רומניה - רומנית - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

novo nordisk a/s - danemarca - somatropinum - sol. inj. in stilou injector preumplut - 10mg/1,5ml - hormoni ai lobului hipofizar anterior hormon somatotrop si agonisti ai acestuia

מולדובה - רומנית - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

changchun genescience pharmaceutical co., ltd. - somatropinum - pulbere pentru soluţie injectabilă - 10 ui

מולדובה - רומנית - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

biosidus s.a. - somatropinum - pulbere şi solvent pentru soluţie injectabilă - 16 u.i. (5,32 mg)

האיחוד האירופי - רומנית - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - ciclesonide - sistemul respirator, alte medicamente pentru afecțiuni obstructive ale căilor respiratorii, inhalante - cai - pentru reducerea semnelor clinice de equine severe de astm (anterior cunoscut sub numele de obstrucție a căilor respiratorii recurente – (rao), vara pășune asociate obstrucție a căilor respiratorii recurente – (spa-rao)).

רומניה - רומנית - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

divapharma gmbh - germania - combinatii - spray bucofaringian,sol - medicamente pentru zona oro-faringiana antiseptice

האיחוד האירופי - רומנית - EMA (European Medicines Agency)

nova laboratories ireland limited - azathioprine - respingerea grefei - imunosupresoare - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

רומניה - רומנית - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lek pharmaceuticals d.d. - slovenia - mometasonum - spray naz.,susp. - 50micrograme/doza - decongestionante si alte medicamente nazale de uz topic corticosteroidiene

רומניה - רומנית - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

schering-plough labo n.v. - belgia - mometasonum - spray nazal susp. - 50micrograme/doza - decongestionante si alte medicamente nazale de uz topic corticosteroidiene

רומניה - רומנית - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

mcneil ab - suedia - nicotinum - spray bucofaringian, sol. - 1mg/spray - med. pentru tratamentul dependentei de substante med. utilizate in tratamentul dependentei de nicotina

רומניה - רומנית - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

farmea - franta - mometasonum - spray naz., susp. - 50micrograme/doza - decongestionante si alte medicamente nazale de uz topic corticosteroidiene